Published in Bone on April 27, 2006
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation. J Bone Miner Res (2009) 1.21
Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility. Calcif Tissue Int (2009) 1.04
CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Bone (2009) 0.99
PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. J Bone Miner Res (2009) 0.95
Indentation of bone tissue: a short review. Osteoporos Int (2009) 0.91
Bone mineralization: from tissue to crystal in normal and pathological contexts. Osteoporos Int (2012) 0.85
Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates. J Child Orthop (2012) 0.85
Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Osteoporos Int (2016) 0.85
Demineralization-remineralization dynamics in teeth and bone. Int J Nanomedicine (2016) 0.81
Recent developments in osteogenesis imperfecta. F1000Res (2015) 0.80
Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone. Bone (2008) 0.78
Bone mass and mineralization in osteogenesis imperfecta. Wien Med Wochenschr (2015) 0.77
Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta. Bone (2014) 0.76
Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta. Skeletal Radiol (2012) 0.76
Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization. J Clin Endocrinol Metab (2016) 0.75
Hypermineralization and high osteocyte lacunar density in osteogenesis imperfecta type V bone indicate exuberant primary bone formation. J Bone Miner Res (2017) 0.75
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet (2006) 7.53
Materials become insensitive to flaws at nanoscale: lessons from nature. Proc Natl Acad Sci U S A (2003) 6.22
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2010) 6.00
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (2013) 5.93
Osteogenesis imperfecta. Lancet (2004) 5.88
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2013) 5.76
CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell (2006) 4.10
Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat (2007) 3.93
Skeleton of Euplectella sp.: structural hierarchy from the nanoscale to the macroscale. Science (2005) 3.75
High abrasion resistance with sparse mineralization: copper biomineral in worm jaws. Science (2002) 3.69
Cell-wall recovery after irreversible deformation of wood. Nat Mater (2003) 3.09
The role of wheat awns in the seed dispersal unit. Science (2007) 3.03
From brittle to ductile fracture of bone. Nat Mater (2005) 2.76
Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci U S A (2006) 2.68
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2008) 2.57
Iron-clad fibers: a metal-based biological strategy for hard flexible coatings. Science (2010) 2.57
Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res (2002) 2.56
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone (2008) 2.53
Nanoscale deformation mechanisms in bone. Nano Lett (2005) 2.48
Reversible switching of hydrogel-actuated nanostructures into complex micropatterns. Science (2007) 2.42
Mutations in WNT1 are a cause of osteogenesis imperfecta. J Med Genet (2013) 2.32
Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci U S A (2010) 2.16
Nucleation and growth of magnetite from solution. Nat Mater (2013) 1.91
Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2009) 1.90
Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res (2011) 1.83
Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab (2003) 1.82
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab (2003) 1.71
Actuation systems in plants as prototypes for bioinspired devices. Philos Trans A Math Phys Eng Sci (2009) 1.67
Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment. J Bone Miner Res (2010) 1.61
Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ (2005) 1.60
The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest (2002) 1.59
Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab (2004) 1.53
Osteogenesis Imperfecta: update on presentation and management. Rev Endocr Metab Disord (2008) 1.52
Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density. Bone (2013) 1.52
Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. J Pediatr (2002) 1.50
Sclerostin deficiency is linked to altered bone composition. J Bone Miner Res (2014) 1.49
Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta. J Pediatr (2006) 1.49
Mineralization pattern of vertebral bone material following fragility fracture of the spine. J Orthop Res (2012) 1.43
Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res (2002) 1.43
Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom (2008) 1.41
Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab (2003) 1.38
Plants control the properties and actuation of their organs through the orientation of cellulose fibrils in their cell walls. Integr Comp Biol (2009) 1.33
Cellulose microfibril orientation of Picea abies and its variability at the micron-level determined by Raman imaging. J Exp Bot (2009) 1.32
Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res (2006) 1.32
The effect of geometry on three-dimensional tissue growth. J R Soc Interface (2008) 1.30
Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet (2007) 1.29
Structures in the cell wall that enable hygroscopic movement of wheat awns. J Struct Biol (2008) 1.28
Evidence for an elementary process in bone plasticity with an activation enthalpy of 1 eV. J R Soc Interface (2007) 1.27
Modern approach to children with osteogenesis imperfecta. J Pediatr Orthop B (2003) 1.26
Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res (2009) 1.24
Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients. J Med Genet (2013) 1.21
Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res (2006) 1.20
Origami-like unfolding of hydro-actuated ice plant seed capsules. Nat Commun (2011) 1.20
Stress generation in the tension wood of poplar is based on the lateral swelling power of the G-layer. Plant J (2008) 1.20
Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res (2004) 1.18
Size-controlled hydroxyapatite nanoparticles as self-organized organic-inorganic composite materials. Biomaterials (2005) 1.16
Zinc and mechanical prowess in the jaws of Nereis, a marine worm. Proc Natl Acad Sci U S A (2003) 1.16
Architecture of the osteocyte network correlates with bone material quality. J Bone Miner Res (2013) 1.15
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone (2006) 1.15
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone (2005) 1.13
Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res (2005) 1.12
Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J Biol Chem (2010) 1.12
X-ray vector radiography for bone micro-architecture diagnostics. Phys Med Biol (2012) 1.11
The grinding tip of the sea urchin tooth exhibits exquisite control over calcite crystal orientation and Mg distribution. Proc Natl Acad Sci U S A (2009) 1.11
Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone (2007) 1.11
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics (2003) 1.11